ByteBrief

Best read upright.

We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.

(We tried widescreen once. It wasn't us.)

ByteBrief

HealthET Techabout 1 hour ago

FDA Issues Class I Recall for Vitruvias Thyroid Tablets

4 min read

The FDA has issued a Class I recall for one lot of Vitruvias Therapeutics Thyroid Tablets, USP 30 mg, after the medicine was found potentially superpotent and may contain more thyroid hormone than intended. Patients taking Lot 504950 should contact their healthcare provider because of serious health risks.

Level

Hype check

Tap to vote and see what everyone thinks.

#fda #recall #health